LEADER 01652nmm a2200385 u 4500
001 EB001902372
003 EBX01000000000000001065281
005 00000000000000.0
007 cr|||||||||||||||||||||
008 201006 ||| eng
100 1 |a Parmar, Mahesh K. B. 
245 0 0 |a Remdesivir COVID-19 clinical trial  |h Elektronische Ressource  |c Mahesh Parmar 
260 |a London  |b Henry Stewart Talks  |c 2020, 2020 
300 |a 1 streaming audio file (12 min.)) 
505 0 |a Contents: Overview of Remdesivir -- Overview of the clinical trial -- Current outcomes -- Next steps for the clinical trial -- Published preliminary report: Beigel J. H, et al. New England Journal of Medicine 2020. doi:10.1056/NEJMoa2007764 
653 |a Communicable Diseases, Emerging / drug therapy 
653 |a COVID-19 
653 |a severe acute respiratory syndrome coronavirus 2 
653 |a Pneumonia, Viral / drug therapy 
653 |a Clinical trials 
653 |a remdesivir 
653 |a Ribonucleotides 
653 |a Clinical Trials as Topic 
653 |a Antiviral agents / Development 
653 |a COVID-19 (Disease) / Research 
653 |a Coronavirus Infections / drug therapy 
653 |a Antiviral Agents / administration & dosage 
653 |a Coronavirus infections / Chemotherapy 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Research and clinical interviews 
500 |a Audio interview. - Title from title frames. - Mode of access: World Wide Web 
856 4 0 |u https://hstalks.com/bs/4317  |x Verlag  |z Streaming video file 
856 4 2 |u https://hstalks.com/bs/p/1060  |3 Series 
082 0 |a 570